Navigation Links
Johns Hopkins University Applied Physics Lab Group Joins OrthoCare Innovations
Date:6/3/2009

OKLAHOMA CITY, June 3 /PRNewswire/ -- OrthoCare Innovations is pleased to announce the addition of Johns Hopkins Applied Physics Laboratory (APL) researchers Stuart Harshbarger, in the role of Chief Scientific Officer, and Matthew Kozlowski Ph.D., as Director of Robotic Systems.

(Photo: http://www.newscom.com/cgi-bin/prnh/20090603/DA26807)

A member of the principal professional staff at APL, Mr. Harshbarger has served as program manager and systems supported integrator for over $100 million in federally supported research over the past four years. His portfolio included the Defense Advanced Research Projects Agency (DARPA) sponsored Revolutionizing Prosthetics 2009 Program. Mr. Harshbarger will continue to serve as Principal Investigator on the DARPA program in his capacity with OrthoCare, and will maintain an affiliation with Johns Hopkins University through an appointment as a Principal Research Scientist in the Department of Electrical and Computer Engineering.

In his DARPA role, leading what is arguably the largest and most ambitious domestic prosthetic research and development initiative in many decades, Mr. Harshbarger and his team have been widely recognized for their work with awards including: the 2009 IEEE/EE Times Creativity in Electronic Design Award, the "2009 Technology Winner" by the IEEE Spectrum Magazine and the 2007 Popular Mechanics Technology Breakthrough Award.

"I am honored to be joining the OrthoCare Innovations team. Having worked closely with the Company as both a Scientific Advisory Board Member and a customer, I have been consistently impressed with both the talent and personal commitment of the OrthoCare staff to improving the state of rehabilitation technologies and quality of life outcomes," commented Mr. Harshbarger. "I am excited to be able to play a key role in the growth of the Company, while also maintaining my close collaboration with my colleagues at Johns Hopkins, to affect the transition of emerging dual-use technologies from the research laboratory into clinical practice."

"The addition of this world-class talent led by Stuart Harshbarger is a testament to the quality and strength of our team, our technologies and our strategic vision," commented OrthoCare CEO Doug McCormack. "This additional capacity will enhance OrthoCare's ability to execute on its business plan and make a significant contribution to the field."

Joining Mr. Harshbarger is Dr. Matthew Kozlowski, a lead engineer in the biomedicine and National Security Technology groups at APL. Dr. Kozlowski, who received his Ph.D. in Mechanical Engineering from Duke University, has played a key role in the DARPA Revolutionizing Prosthetics 2009 Program. His current work in the area of robotics includes the development of advanced dexterity for future ground explosive ordnance disposal robot systems. He also leads the common architecture and overall systems engineering efforts for the Navy's Advanced Explosive Ordnance Disposal Robot Systems.

About OrthoCare Innovations

OrthoCare Innovations is a medical device research and product development company focused on bringing to market advanced, innovative technologies to improve clinical efficiency and enhance the quality of patient care services in the rehabilitation, prosthetic and orthotic markets. For more information, go to www.orthocareinnovations.com.


'/>"/>
SOURCE OrthoCare Innovations
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Johnson & Johnson Files Arbitration Demand Against Schering-Plough to Resolve Dispute Over Agreements for REMICADE(R) and SIMPONI(TM)
2. Boston Scientific Announces Two Directors Leave Board as Burns Named CEO of Xerox and Johnson Confirmed as Under Secretary of Energy
3. Champions Shawn Johnson & Phil Jackson Wear Energy Muse Jewelry
4. Johnson & Johnson to Participate in Deutsche Bank 34th Annual Health Care Conference
5. Johnson & Johnson to Host Analyst Conference Call To Review Six-Month Trial Results From NEVO RES I
6. EF Johnson Technologies, Inc. Announces First Quarter 2009 Financial Results
7. Johnson & Johnson to Participate in Bank of America and Merrill Lynch 2009 Health Care Conference
8. Weill Cornell and Cornells Johnson School present first annual business and medicine symposium
9. Johnson & Johnson to Webcast Annual Meeting of Shareholders
10. Johnson & Johnson Reports 2009 First-Quarter Results:
11. Trust for Americas Health Supports Recommendations from Robert Wood Johnson Foundation Commission to Build a Healthier America
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/26/2016)... , ... June 26, 2016 , ... Pixel Film Studios ... X. , "Film editors can give their videos a whole new perspective by using ... - CEO of Pixel Film Studios. , ProSlice Levels contains over 30 Different ...
(Date:6/26/2016)... ... June 26, 2016 , ... Many ... been diagnosed with endometriosis. These women need a treatment plan to not only ... approach that can help for preservation of fertility and ultimately achieving a pregnancy. ...
(Date:6/25/2016)... ... ... The temporary closing of Bruton Memorial Library on June 21 due to a possible lice ... overlooked aspect of head lice: the parasite’s ability to live away from a human host, ... a necessary one in the event that lice have simply gotten out of control. , ...
(Date:6/25/2016)... ... , ... As a lifelong Southern Californian, Dr. Omkar Marathe earned his Bachelors ... Geffen School of Medicine at UCLA. He trained in Internal Medicine at Scripps Green ... hematology/oncology at the UCLA-Olive View-Cedars Sinai program where he had the opportunity to train ...
(Date:6/25/2016)... ... June 25, 2016 , ... Conventional wisdom preaches the ... In terms of the latter, setting the bar too high can result in disappointment, ... just slow progress toward their goal. , Research from PsychTests.com reveals ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... -- Roche (SIX: RO, ROG; OTCQX: RHHBY) announced that ... PCT (procalcitonin) assay as a dedicated testing solution for ... clearance, Roche is the first IVD company in the ... risk assessment and management. PCT is a ... in blood can aid clinicians in assessing the risk ...
(Date:6/23/2016)... Calif. , June 23, 2016 ... CST on Thursday, July 7, 2016 , , , , ... ) , , , , EXPERT PANELISTS:  , , ... Naik; Senior Industry Analyst, Christi Bird; Senior Industry Analyst, Divyaa Ravishankar ... The global pharmaceutical industry is witnessing an exceptional ...
(Date:6/23/2016)... -- The vast majority of dialysis patients currently receive ... usually 3 times a week, with treatment times averaging ... equipment preparation and wait time.  This regimen can be ... who are elderly and frail.  Many elderly dialysis patients ... for some duration of time. Residents in ...
Breaking Medicine Technology: